Oxidative stress and death domain proteins in Alzheimer's disease

Clinical Neuroscience Research

Volumn 2, Issue 5-6, 2003, Pages 316-323

  Villar, Keith Del ^a   Miller, Carol A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Death domain; Environmental stresses

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; AMYLOID BETA PROTEIN; FAS LIGAND; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; PROTEIN MITOGEN ACTIVATED KINASE ACTIVATING DEATH DOMAIN PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; BRAIN INFARCTION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; MACROPHAGE ACTIVATION; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGENERATION; SIGNAL TRANSDUCTION; STRESS;

EID: 4344585326     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1566-2772(03)00008-2     Document Type: Conference Paper

References (74)

1. Hensley K, Floyd RA, Zheng N-Y, et al. p38 kinase is activated in the Alzheimer's disease brain. J Neurochem 1999;72:2053-8.
2. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326.
3. Impey S, Obrietan K, Storm DR. Making new connection: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 1999;23: 11-4.
4. Herzog K-H, Chen S-C, Morgan JI. C-Jun is dispensable for developmental cell death and axogenesis. J Neurosci 1999;19(11): 4349-59.
5. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999;19(4): 2435-44.
6. 2-terminal kinase, p38 and extracellular signal-regulated kinase 5. Mol Cell Biol 1999;19(6): 4289-301.
7. 1. J Immunol 1996;157(8):3381-90.
8. Leppä S, Saffrich R, Ansorge W, Bohmann D. Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J 1998;17(15):4404-13.
9. Kyriakis J, Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. BioEssays 1996;18:567-77.
10. Muda M, Theodosiou A, Rodrigues N, et al. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 1996; 1(271(44)):2705-8.
11. Herdegen T, Claret FX, Kallunki T, et al. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci 1998;18:5124-35.
12. Gupta S, Barrett T, Whitmarsh AJ, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 1996; 15(11):2760-70.
13. 3F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system. Neuron 1995;14:67-78.
14. 3F12 SAP kinase. Mol Brain Res 1996;35:47-57.
15. Kumagae Y, Zhang Y, Kim OJ, Miller CA. Human c-Jun N-terminal kinase expression and activation in the nervous system. Mol Brain Res 1999;67:10-7.
16. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: sequencing and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989;3:519-26.
17. Spillantini MG, Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998;21(10):428-33.
18. Anderson A, Cumming B, Cotman W. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: association with pathology. Exp Neurol 1994;125:286-95.
19. Matsuo ES, Shin R-W, Billingsley ML, et al. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994;13: 989-1002.
20. Reynolds CH, Utton MA, Gibb GM, Yates A, Anderton BH. Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylates τ protein. J Neurochem 1997;68(4):1736-44.
21. Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P. Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other stress kinases. EMBO J 1997;6: 3563-74.
22. Lawler S, Cuenda A, Goedert M, Cohen P. SKK4, a novel activator of stress-activated protein kinase-1 (SAPK1/JNK). FEBS Lett 1997; 414(1):153-8.
23. Latimer DA, Gallo J-M, Lovestone S, et al. Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau. FEBS Lett 1995;365:42-6.
24. Takashima A, Murayama M, Murayama O, et al. Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau. PNAS, USA 1998;95:9637-41.
25. Ham J, Babij C, Whitfield J, et al. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 1995;14:927-39.
26. Mesner PW, Epting CL, Hegarty JL, Green SH. A timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells. J Neurosci 1995;15(11):7357-66.
27. Ip YT, Davis RJ. Signal transduction by the c-Jun NH-terminal kinase (JNK) from inflammation to development. Curr Opin Cell Biol 1998; 10:205-19.
28. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs and Tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 1997;7:67-74.
29. Koh JY, Yang LL, Cotman CW. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990;533:315-20.
30. Schwarzschild MA, Cole RL, Hyman SE. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1 mediated transcription in striatal neurons. J Neurosci 1997;17(10): 3455-66.
31. Yang DD, Kuan CY, Whitmarsh AJ, et al. Absence of excitotoxicity induced apoptosis in the hippocampus of mice lacking the JNK3 gene. Nature 1997;389:865-70.
32. Kuan C-Y, Yang DD, Koy DRS, et al. The JNK1 and JNK2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999;22:667-76.
33. Yasuda J, Whitmarsh AJ, Cavanagh J, Sharma M, Davis RJ. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol Cell Biol 1999;19(10):7245-54.
34. Dickens M, Rogers JS, Cavanagh J, et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 1997;277:693-6.
35. Bonney C, Nicod P, Waeber G. IBI, a JIP-1 related nuclear protein present in insulin secreting cells. J Biol Chem 1998;273:1843-6.
36. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999;19(4): 2435-44.
37. Whitmarsh AJ, Cavanagh J, Tournier C, Yasuda J, Davis RJ. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 1998;281:1671-4.
38. Elion RA. Routing MAP kinase cascade. Science 1998;281:1625-6.
39. Morishima Y, Gotoh Y, Zieg J, et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 2001;21(19): 7551-60.
40. Kruman I, Bruce A, Bredesen D, Waeg G, Mattson M. J Neurosci 1997;17:6089-100.
41. Keller J, Kindy M, Holtsberg F, Mattson M, et al. J Neurosci 1998;18: 687-97.
42. Shearman MS, Ragan CI, Iversen LI. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. PNAS, USA 1994;91:1470-4.
43. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. PNAS 1993;90:7951-5.
44. Kubo T, Morimoto K, Kumagae Y, Miller CA, Kaneko I. A possible mechanism of neurodegeneration in Alzheimer's disease - involvement of racemized β-amyloid. Soc Neurosci 1999;25(838):3379.
45. 1-42 are potent central nervous system neurotoxins. PNAS, USA 1998;95:6448-53.
46. Stadelmann C, Brück W, Bancher C, Jellinger K, Lassmann H. Alzheimer's disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropath Exp Neurol 1998; 57(5):456-64.
47. Behl C, Davis JB, Klier FG, Schubert D. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res 1994;645:253-64.
48. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci 1997;17(13):5089-100.
49. Keller J, Kindy M, Holtsberg F, et al. Mitochondrial manganese superoxide dismutasse prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. J Neurosci 1998;18(2): 687-97.
50. Perry G, Smith M. Neuronal oxidative stress is a common feature of Alzheimer's and Parkinson's disease. Progress in Alzheimer's and Parkinson's disease. New York 1998;77-80.
51. Gajewski TF, Thompson CB. Apoptosis meets signal transduction: elimination of a BAD influence. Cell 1996;87:589-92.
52. Stancovski I, Baltimore D. NF-κB kinase revealed? Cell 1997;91: 299-302.
53. Yan SD, Fu J, Soto C, et al. An intracellular protein that bind amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature (Lond) 1997;389:689-95.
54. Lander H, Tauras J, Ogiste J, Moss R, Schmidt AM. Activation of RAGE triggers a MAP kinase pathway regulated by oxidant stress. J Biol Chem 1997;272:17810-4.
55. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994;63:601-37.
56. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
57. Gervais FG, Xu D, Robertson GS, et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic A peptide formation. Cell 1999;97:395-406.
58. Selznick LA, Holtzman DM, Han BH, et al. In situ immunodetection of neuronal caspase-3 activation in Alzheimer's disease. J Neuropathol Exp Neurol 1999;58(9):1020-6.
59. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999;17:331-67.
60. Schievella AR, Chen JH, Graham JR, Lin L. MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinases. J Biol Chem 1997;272:12069-75.
61. Chow VTK, Lee SS. DENN, a novel human gene differentially expressed in normal and neoplastic cells. DNA Seq 1996;6:263-73.
62. Zhang Y, Zhou L, Miller CA. A splicing variant for a death domain protein that is regulated by a mitogen-activated kinase is a substrate for c-Jun N-terminal kinase in the human central nervous system. PNAS 1998;95:2586-91.
63. Iwasaki K, Staunton J, Saifee O, Nonet M, Thomas JH. AEX-3 encodes a novel regulator of presynaptic activity in C. elegans. Neuron 1997;18(4):613-22.
64. 2+-dependent exocytosis. J Biol Chem 1998;273(51):34580-5.
65. Wada M, Nakanishi H, Satoh A, et al. Isolation and characterization of a GDP/GTP exchange protein specific for the Rab3 subfamily small G protein. J Biol Chem 1997;272(7):3875-8.
66. Mattson MP, Barger SW, Furukawa K, et al. Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease. Brain Res Rev 1997;23:47-61.
67. Natoli G, Costanzo A, Ianni A, et al. Activation of SAPK/JNK by TNF receptor through a non-cytotoxic TRAF2-dependent pathway. Science 1997;275:200-3.
68. Murakami-Mori K, Mori S, Bonavida B, Nakamura S. Implication of TNF receptor-1-mediated extracellular signal-regulated kinases 1 and 3 (ERK1/2) activation in growth of AIDS-associated kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-α-induced ERK1/2 activation in Kaposi's sarcoma cells'. J Immunol 1999;162:3672-9.
69. Wilson DJ, Fortner KA, Lynch DH, et al. Eur J Immunol 1996;26: 989-94.
70. Ivins KJ, Ivins JK, Sharp JP, Cotman CW. Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by β-amyloid. J Biol Chem 1999;274(4):2107-12.
71. London JA, Biegel D, Pachter JS. Neurocytopathic effects of β-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer's disease. PNAS 1996;93: 4147-52.
72. Tartaglia LA, Merrill A, Wong GW, Goedell DV. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993;74: 845-54.
73. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995; 81(4):495-504.
74. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996;87(3):565-76.